Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding support for 3 more conditions and noting that the study now includes 238 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.3%
    Check dated 2024-07-22T15:30:17.000Z thumbnail image
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated with a new revision v2.9.7, replacing the estimated last update posted with the actual last update posted information.
    Difference
    0.1%
    Check dated 2024-07-16T11:18:40.000Z thumbnail image
  7. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated with new information as of July 12, 2024, including actual data and the last update posted on May 20, 2024.
    Difference
    0.7%
    Check dated 2024-07-13T05:20:08.000Z thumbnail image
  8. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T02:24:37.000Z thumbnail image
  9. Check
    17 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-10T01:33:14.000Z thumbnail image
  10. Check
    23 days ago
    Change Detected
    Summary
    The value Ovarian Epithelial Cancer Fallopian Tube Cancer has recently changed to Fallopian Tube Cancer Ovarian Epithelial Cancer. This change represents a reversal in the order of the terms, indicating a switch in the primary focus or emphasis of the study from ovarian epithelial cancer to fallopian tube cancer.
    Difference
    0.2%
    Check dated 2024-07-03T18:05:54.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.